Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Senorics is a high-tech spin-off from the University of Dresden that specializes in the development and manufacturing of organic near-infrared (NIR) sensor solutions. The company's proprietary technology enables the miniaturization of NIR spectroscopy, allowing for the integration of powerful material analysis tools into small, cost-effective devices. Their sensors are used across various industries, including food and agriculture for quality control, and the pharmaceutical industry for the identification and quantification of raw materials and active ingredients. By providing real-time, non-destructive analysis, Senorics empowers businesses and consumers to make data-driven decisions about the composition of materials. The company's platform is based on organic semiconductors, which offer significant advantages in terms of size, weight, and scalability compared to traditional silicon-based sensors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Senorics.